[Association of cellular inhibitor of apoptosis protein-2 expression with clinical outcomes of hepatocellular carcinoma].

MLA

Bi, Minping, et al. “[Association of Cellular Inhibitor of Apoptosis Protein-2 Expression with Clinical Outcomes of Hepatocellular Carcinoma].” Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University, vol. 32, no. 7, June 2012, p. 1020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=22820591&authtype=sso&custid=ns315887.

APA

Bi, M., Yang, D., Li, X., Zhong, K., Liu, Y., Li, G., Liao, X., & Liu, X. (2012). [Association of cellular inhibitor of apoptosis protein-2 expression with clinical outcomes of hepatocellular carcinoma]. Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University, 32(7), 1020.

Chicago

Bi, Minping, Dinghua Yang, Xianghong Li, Kebo Zhong, Yan Liu, Guanghui Li, Xiaoming Liao, and Xiao Liu. 2012. “[Association of Cellular Inhibitor of Apoptosis Protein-2 Expression with Clinical Outcomes of Hepatocellular Carcinoma].” Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University 32 (7): 1020. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=22820591&authtype=sso&custid=ns315887.